These companies enjoy explicit exemptions from the 15% global tariffs, giving them a significant competitive edge over rivals facing increased import costs. This policy protection could translate directly into improved profit margins.
With strong domestic supply chains and manufacturing bases, these businesses are positioned to capture market share as competitors struggle with higher tariffed costs. The timing couldn't be better for US-focused operations.
This isn't about long-term trends - it's about capitalising on an immediate policy change that creates winners and losers overnight. These companies are on the winning side of a major trade shift.
This basket's total market capitalisation is $1.18T, and it is anchored by several very large-cap stocks, which tend to provide a relatively stable, lower-risk profile.
BA: $182.22B
GM: $73.68B
LMT: $151.45B
President Trump's new 15% global tariff creates a significant advantage for companies in exempt sectors. By specifically excluding aerospace, defence, and automotive industries from these duties, these businesses can now operate with lower costs compared to competitors facing increased import expenses. This policy shift presents a tactical investment opportunity in companies positioned to benefit from this competitive edge.
This collection focuses on companies within the exempted sectors that can capitalise on the new trade landscape. These businesses may see improved profit margins and market share as their competitors face higher costs from tariffed imports. The theme is event-driven, designed to capture the immediate effects of this significant change in U.S. trade policy on specific industries.
Each company was selected because it operates within the aerospace, defence, or automotive sectors that received explicit exemptions from the tariffs. These businesses are positioned to benefit from reduced competitive pressure as rivals face increased costs. The selection includes major manufacturers and suppliers with domestic operations that stand to gain from this policy advantage.
President Trump's new 15% global tariff on imports is set to reshape trade dynamics by increasing the cost of foreign goods. This creates a potential advantage for companies in exempt sectors like aerospace and autos, as well as businesses with domestic-focused supply chains.
Published on February 22
+3
Here are a few of the assets in this group. Create an account to unlock the full list.
Get the full story on this Basket. Read our detailed article on its risks and potential.
Read Full Insight
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Part of Exinity Group 2015, serving over a million customers globally.
Earn 6% AER on uninvested cash with daily interest payments.
On average, analysts expect assets in this group to grow 11.2% over the next year.
12 of 13 assets in this group are rated Buy by professional analysts.
Use the growth calculator to see how much investing in these assets could return over one year, based on aggregated analyst sentiment provided by Refinitiv Ltd.
If you invested across these assets:
In 12 months it might be worth:
+11.20%
Gilead Sciences has secured FDA approval for a new once-daily HIV combination pill, streamlining therapy for millions of suppressed patients. This regulatory milestone spotlights investment opportunities in pioneering biopharmaceutical companies and drug delivery developers focused on advanced antiviral treatments.
Disney is suing the FCC to block an early license review of its ABC stations, arguing the move is politically motivated retaliation against its news coverage. This unprecedented legal battle highlights the growing regulatory risks for traditional broadcasters and underscores the structural advantages of unregulated digital streaming platforms.
SK Hynix has unveiled a record-breaking 40 trillion won share buyback fueled by soaring demand for its AI memory chips. This historic capital return creates a compelling investment theme centered on high-bandwidth memory producers and the specialized equipment manufacturers that enable their advanced production.
